2021-12-31-accounts

THE BRITISH SOCIETY FOR CELL BIOLOGY FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021 Registered Charity number: 265816

Jacob Cavenagh & Skeet 5 Robin Hood Lane Sutton Surrey SM1 2SW

THE BRITISH SOCIETY FOR CELL BIOLOGY

FINANCIAL STATEMENTS FOR THE

YEAR ENDED 31 DECEMBER 2021

Contents

Contents	Page
Ofcers and Advisers	1
Executive Committee’s Report	2-7
Independent Examiner’s Report	8
Statement of Financial Activities	9
Balance Sheet	10
Notes to the Financial Statements	11-14

P a g e | 1

THE BRITISH SOCIETY FOR CELL BIOLOGY Reference of Administrative Details

Trustees/Officers: Anne Ridley (President) Giampietro Schiavo (Treasurer appointed 03.04.2022) David Elliott (Treasurer resigned 03.04.2022) Carine De Marcos Lousa (Secretary) Jason King (Membership secretary) Anne Straube (Meetings secretary resigned 01.11.21) Susana Godinho (Meetings secretary appointed 01.11.21) Sharon Tooze (Honor Fell secretary) Folma Buss (Honor Fell secretary) Ann Wheeler (Newsletter secretary) Stephen Robinson Other Executive Committee Members: Maria Balda (Summer studentships) Alex Fellows Victoria Cowling Viji Draviam Jenny Rohn Darius Koester Ciaran Morrison Tom Nightingale Rowan Taylor Co-opted Committee Members: David Archer (Schools Liaison) Key Management Personnel: Prof A Ridley ( President ) Prof G Schiavo ( Treasurer ) Carine De Marcos Lousa ( Secretary ) Bankers: HSBC Bank plc Arlington Business Centre Millshaw Park Lane Leeds LS11 0PA National Savings Glasgow G58 1SB Virgin Money, Jubilee House, Gosforth Newcastle NE3 4PL Nationwide, 117 High Street Gosforth Newcastle NE3 1HA Independent Examiner: Miriam Hickson CTA FCA 5 Robin Hood Lane Sutton Surrey SM1 2SW Contact Address: c/o Prof G Schiavo Queen Square Institute of Neurology University College London Queen Square London WC2N 3BG

P a g e | 2

THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

The Officers (who are the trustees of the Society for the purposes of charity law) have pleasure in presenting their report and the independently examined accounts of the Society for the year ended 31 December 2021. These accounts have been prepared in accordance with the Charities Act 2011, the Statement of Recommended Practice (Charities SORP 2015 (FRS102)), Financial Reporting Standard 102 (FRS 102); and the constitution of the Society.

Structure, Governance and Management

Officers and committee

Under the constitution of the Society, the Officers of the Society are a President, a Secretary, a Treasurer, a Meetings Convenor, a Membership Secretary, a Newsletter Editor and a Website Co-ordinator. There is also an Executive Committee of the Society consisting of the Officers and twelve other elected members.

The Executive Committee is elected at the Annual General Meeting, with the Officers being elected by the Executive Committee and the President being nominated by the Executive Committee.

The trustees are trained by having an at least 1 year transition period in which case the new trustee shadows the previous trustee, thus ensuring they know how to fill the role.

The Executive Committee prepares the Agenda for meetings of the Society, and between meetings acts as necessary on behalf of the Society; reporting on any such actions to the next meeting of the Society.

The individuals who served as Officers and Executive Committee members during the year, and since the year-end, were as follows:

Dr D Archer	(Joined1998)	Dr C de Marcos Lousa	Dr C de Marcos Lousa	(Joined
2018)
		Dr J King	(Joined	2018)
		Prof C Morrison	(Joined	2019)
Dr A Straube	(Joined2015)
Dr V Ponnambalam	(Joined 2015)	Ms R Taylor	(Joined	2020)
		Prof V Cowling		(Joined
2020)
Prof M Balda	(Joined 2016)	Dr T Nightingale	(Joined	2020)
Prof D Elliott	(Joined 2016)	Prof G Schiavo		(Joined
2020)
Dr A Wheeler	(Joined 2016)	Dr A Fellows	(Joined	2020)
Dr S Godinho	(Joined 2017)	DrD Koester	(Joined	2021)
Dr F Buss	(Joined 2017)	Prof V Draviam		(Joined
2021)
Dr S Tooze	(Joined 2017)
Prof A Ridley	(Joined 2017)
Dr S Robinson	(Joined 2017)
Dr J Rohn	(Joined 2017)

Page 13

P a g e | 4

THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 (CONTINUED)

The Executive Committee members in office at the date of this report are detailed on the previous page. The Key Management Personnel of the charity as listed on page 1 are in charge of directing, controlling, running and operating the charity on a day to day basis. No remuneration is paid to any of the Key Management Personnel or the other trustees.

Constitution

The Society is constituted under a constitution executed in 1965 and amended in 2014. The Society is a registered charity, number 265816.

Risk assessment

The major risks to which the Society is exposed, as identified by the Executive Committee, have been reviewed in the year and systems are in place to mitigate those.

As we are a society, one major risk is a drop in numbers of members. To mitigate this risk, we have introduced easier ways of maintaining membership via direct debit, and introductory packages for PhD students that include 3 years membership at reduced rate. We hope that once students see the benefit of membership they will continue once they graduate.

Objectives and Activities

The objects of the Society are to promote the advancement of research in relation to all branches of cell biology and to encourage the interchange of information and support career development. The Society generally aims to fulfil these objects by organising and sponsoring meetings each year on topics relevant to cell biology; funding travel grants to PhD students, postdoctoral scientists and group leaders; Funding training courses in Cell Biology for early career scientists; Issuing a yearly newsletter and maintaining a website (www.bscb.org).

The Executive Committee confirm that they have had due regard to the guidance issued by the Charity Commission relating to public benefit.

Achievements and Performance

The Company of Biologists awarded the BSCB with a Block Grant of £35,000 in 2020, and also kindly allowed us to carry over funding for our HF Travel Grants, and grants for PI travel and Practical Courses. The support provided by the Company of Biologists (COB) is vitally important for the BSCB and enables it to promote Cell Biology within the UK across schools, universities and to support the research community. Given the continuing worldwide COVID-19 pandemic, all in person conferences and meetings planned for this year have been cancelled. As a result of this we have not spent much of the Travel grants. We have been supporting science in other ways for which we have used our block grant.

Membership: We currently have 961 members, of which 352 are students. We recruited 122 new members this year, and are going to have new membership initiatives in the autumn to catch new students. Our membership fulfilment services are provided by HG3 Ltd.

Scientific Networking : Normally much of the activity of the BSCB is centered around organising world-class scientific meetings for the Cell Biology community. Unfortunately, in person meetings have been affected by the pandemic. In Spring 2021 we held a joint meeting with the Biochemical Society (Dynamic Cell IV), that was held

P a g e | 5

virtually. This event was successful - with 236 participants, national and international speakers, BSCB-funded poster prizes for PhD students and postdocs (1st, 2nd, and 3rd), and special sessions, including on grant writing, that were well attended and interactive.

THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 (CONTINUED)

Career development. At our Dynamic Cell IV Meeting our postdoc and PhD representatives (1) ran a student/postdoc symposium, choosing 10 speakers from 70 submitted abstracts; (2) a careers event; (3) an interactive discussion about social media in science; and (4) organized the pub quiz and a “meet the medal winners” event. The BSCB committee also launched a brand-new scheme for supporting regional meetings run by PhD students and postdocs on careers and networking. This is advertised now on our website. Given the current COVID-19 situation we have not had many applications, but we hope this will pick up when in-person meetings are possible again. We are encouraging these events to include more than one institution, and to be open to members from across the UK.

Summer Internships: These awards are to encourage the very best undergraduate students to consider research careers in the field of Cell Biology. Awards were based on competitive application, scored by 6 members of the BSCB committee. We received 32 applications and chose 12 for funding in 2021. These research projects were asked to be designed so that they could be carried out remotely, if necessary, e.g., using bioinformatics approaches, with a description of how remote supervision would be conducted. We also increased our stipend to £300/week (to be in line with the minimum wage for under 23s, which is £8.20 for a 36.5-hour week), and most projects are for 8 weeks. Each of the students will produce a report, some of which will be published in our annual BSCB newsletter Magazine.

Scientific Awards: We continued to promote Cell Biology in the UK by awarding prestigious scientific prizes at multiple career levels. The Hooke medal is awarded to an outstanding cell biologist who started their own lab within the last 14 years. This year we awarded our Hooke Medal to Stephen Royle of the University of Warwick for his work on membrane trafficking and mitosis in human cells. Another senior award is the Women in Cell Biology (WICB) Early Career Medal, which was established in 2015 to mark the 50[th] anniversary of the founding of the BSCB. It is an annual honour awarded to an outstanding female cell biologist who has started her own research group in the UK within the last seven years. In 2021, the WICB award went to Vivian Li of the Francis Crick Institute in London for her work on the regulation of intestinal homeostasis and cancer. This BSCB award contributes to recognising women’s success and provides role models

for future generations. These prize winners are displayed on our website. Both Stephen and Vivian were awarded their prizes by our president Anne Ridley, at a virtual joint meeting between the BSCB and the French Society for Cell Biology, originally planned in Cell La Vie (F), in September 2021.

This year we also introduced two new prizes. These prizes were conceived and developed by our previous and current BSCB committee postdoc (Gautam Dey, UCL; Alex Fellows, MRC LMB) and PhD (Joyce Yu, Crick Institute; Rowan Taylor, University of Leeds) representatives. This involved the design and manufacture of 2 new medals, with bespoke designs from Beata Science Art being chosen by the BSCB committee.

P a g e | 6

In the BSCB postdoc award we are looking for the next generation of inspirational scientific leaders. The awardee receives free registration, accommodation, and UK/Ireland travel for the next BSCB annual meeting at which they will be presented with a medal and give a short talk. Agathe Chaigne won our first ever Postdoc award. Agathe is a Sir Henry Wellcome postdoctoral fellow at the MRC Laboratory for Molecular Cell Biology, University College London, and discovered a key role for the last step of division, abscission, in regulating exit from naive pluripotency.

THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 (CONTINUED)

Flora Paldi won our inaugural Raff Medal for PhD student research. Flora’s PhD project (University of Edinburgh) focused on the role of pericentromeric chromosome structure in mitotic chromosome segregation. Flora communicated her findings to national and international conferences. Her work was recently published in Nature, and demonstrated a direct, causal relationship between the three-dimensional organisation of a specific domain with cellular function. Flora was also an active member of the PhD scientific community, and is currently a postdoctoral researcher in Montpellier, France. Both Agatha and Flora were awarded their medals virtually this year at our Dynamic Cell meeting (March 2021), and received their medals by post. Details of their work are on our website.

We run two additional competitions each year which are open to junior scientists: the BSCB Science Writing Prize and Image Competition with deadlines in July 2021. The winning essay and images will be presented on our website and in our magazine.

Supporting attendance at scientific meetings . Because attending international meetings is a crucial aspect of early career scientist training, we attempt to fund all eligible applications. This year has been a bit slower because of the worldwide pandemic.

Outreach Activities: Committee member Jenny Rohn from University College London (UCL) is our “Science Advocacy and Outreach Officer”. Again, there has been less on this year because of the pandemic. Jenny has used the email list of interested BSCB members to coordinate our society’s responses to various calls for consultation issued by the Royal Society of Biology (of which we are a Member Organisation). These have included an all-party parliamentary group investigating diversity and inclusion in science, technology, engineering and mathematics (STEM) to promote a diverse and inclusive environment; and a DEFRA (Department of Environment, Food and Rural Affairs) consultation on non-human genome editing and genetically modified organisms. Key science policy information is shared with our membership via the website and Magazine

We recently published our 2021 BSCB Magazine to publicize the BSCB and our work, and we maintain an active twitter feed. The BSCB magazine is in colour, and posted to all members as well as being available on our website. Tom Nightingale and Ciaran Morrison are taking over as committee members responsible for the Magazine from Ann Wheeler.

P a g e | 7

We continue to support public engagement via education, through e-learning pages ‘softCELL and ‘CELLpics’ on our website. David Archer, our Schools Liaison officer, is updating sections on cancer at the moment, and these are going to be uploaded on our website. David also wrote a piece about the effect that Covid-19 was having on children’s education for our Magazine.

Website and Social Media: The BSCB website allows members and the wider cell biology community to keep informed about our activities. The Company of Biologists logo is placed in a prominent position on the top of the sidebar and on every page, and the Company of Biologists’ very generous support is acknowledged on the main landing page text and at various places throughout the site. We also promote the Company of Biologists events and journals on our website and in our Magazine, and through re-tweeting. This year we have a new website officer, Stephen Robinson, who has taken over from Judith Sleeman. Stephen is working to revamp our website this year.

THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 (CONTINUED)

Financial Review

Reserves

The Executive Committee regularly reviews the reserves of the charity to ensure that sufficient liquid funds are available for the Society to meet its ongoing obligations. The trustees require a level of unrestricted free reserves of £125,000 to meet existing and committed expenditure in case income is not received. Total funds at 31 December 2021 were £330,891 (2020 funds: £327,495, and 2019: £249,948). Of these, £78,376 (2020: £81,485) were restricted unspent COB grants. Unrestricted funds, which constitute free reserves were £252,515 (2020: £246,010). The current level of free reserves is therefore higher than is needed to cover all the existing and committed expenditure.

We introduced a vacation studentship scheme in 2011 to provide training opportunities for undergraduate students. These will utilise some of the reserves in a controlled manner over several years.

Investment Policy

The Executive Committee’s policy at present is to invest in low-risk and reasonably liquid assets, so that funds are available to meet any unforeseen needs that arise because of meeting activities.

Future Plans

We have an exciting joint meeting planned with the French Society for Cell Biology. We will also support a number of other cell biology meetings in response to funding applications. Planning for future meetings has commenced. We will continue to support

P a g e | 8

1 day focused meetings, summer studentships and more generally Cell Biology in the UK.

THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 (CONTINUED)

Executive Committee’s Responsibilities

The Executive Committee is responsible for preparing the Annual Report and the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice.

Charity law requires the Executive Committee to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the Society and of the surplus or deficit for that period. In preparing those financial statements, the Executive Committee have:

• select suitable accounting policies and then apply them consistently;

• observe the methods and principles in the Charities SORP;

• make judgments and estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.

The Executive Committee has overall responsibility for ensuring that the Society has an appropriate system of controls, financial and otherwise. It is also responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Society. It is also responsible for safeguarding the

P a g e | 9

assets of the Society and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Giampietro Schiavo Trustee

24/06/2022

P a g e | 10

INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF THE BRITISH SOCIETY FOR CELL BIOLOGY

I report to the charity trustees on my examination of the accounts of the Trust (the Trust) for the year ended 31 December 2021.

Responsibilities and basis of report

As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).

I report in respect of my examination of the Trust’s accounts as carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner’s statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or

2. the accounts do not accord with those records; or

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Report) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or

4. the accounts have not been prepared in accordance with the methods and principles of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and the Republic of Ireland (FRS 102)

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Miriam Hickson CTA FCA Jacob Cavenagh & Skeet 5 Robin Hood Lane Sutton Surrey SM1 2SW

Date:

P a g e | 11

THE BRITISH SOCIETY FOR CELL BIOLOGY STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR TO 31 DECEMBER 2021

Not e Unrestrict ed Funds Restrict ed Funds	Not e Unrestrict ed Funds Restrict ed Funds	Not e Unrestrict ed Funds Restrict ed Funds	Not e Unrestrict ed Funds Restrict ed Funds	Not e Unrestrict ed Funds Restrict ed Funds	Total 2021 Unrestrict ed Funds Restricted Funds	Total 2021 Unrestrict ed Funds Restricted Funds	Total 2021 Unrestrict ed Funds Restricted Funds	Total 2021 Unrestrict ed Funds Restricted Funds	Total 2021 Unrestrict ed Funds Restricted Funds	Total 2021 Unrestrict ed Funds Restricted Funds		Total 2020	Total 2020
Income from:		£		£	£			£		£		£
Grants 2		35,000		-	35,000			35,000		62,500		97,500
Investments		36		-	36			887		-		887
Charitable activities
Subscriptions		26,353		-	26,353			30,057		-		30,057
Other income		-		-	-			3,547		-		3,547
Total income		61,389		-	61,389			69,491		62,500		131,99 1
Expenditure on:
Charitable activities
Grants payable:
CoB 4		-		3,109	3,109			-		4,650		4,650
Other grants		148		-	148			1,030		500		1,530
Studentships		29,719		-	29,719			20,865		-		20,865
Costs of meetings		2,537		-	2,537			3,374		-		3,374
Website expenses		728		-	728			588		-		588
Newsletter costs		4,049		-	4,049			4,075		-		4,075
Membership fulflment services		11,609		-	11,609			13,724		-		13,724
Examiner’s remuneration		2,950		-		2,950		2,760		-			2,760
Miscellaneous		163		-		163		219		-			219
Subscriptions		1,558		-		1,558		1,542		-			1,542
Insurance		1,423		-		1,42 3		1,117		-			1,11 7
Total expenditure		54,884		3,109	57,993			49,294		5,150		54,444
Net (expenditure)/inco me		6,505		(3,109)	3,396			20,197		57,350		77,547
Transfer between funds		-		-	-			-		-		-
Net movement in funds		6,505		(3,109)	3,396			20,197		57,350		77,547
Funds brought forward at 1 January 2021	246,010			81,485	327,495		225,813			24,135	249,948

P a g e | 12

Funds carried forward at 31 December 2021

252,515

78,376 330,891 246,010 81,485 327,495

P a g e | 13

THE BRITISH SOCIETY FOR CELL BIOLOGY BALANCE SHEET AS AT 31 DECEMBER 2021

Current assets: Debtors 5 Cash at bank and in hand Liabilities: Creditors: amounts falling due in one year 6 Total assets less current liabilities 7 Funds Restricted funds 4 Unrestricted funds Total funds		2021 £ 1,213 341,815 343,028 12,137 330,891 78,376 252,515 330,891		2020 £ 2,859 337,304
				340,163 12,668
				327,495
				81,485 246,010
				327,495

Approved by the Trustees 24/06/2022 and signed on their behalf by:

Carine Marcos de Lousa Giampietro Schiavo Trustee Trustee

P a g e | 14

THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021

1. Accounting Policies

The Society is constituted under a constitution executed in 1965, and amended in 2014. The Society is a registered charity, number 265816. It’s registered office is C/O Prof G Schiavo, Queen Square Institute of Neurology , University College London , Queen Square, London WC2N 3BG. The Society meets the definition of a public benefit entity under FRS 102.

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows:

a) Basis of accounting

The financial statements are prepared in accordance with the charity’s constitution, the Charities Statement of Recommended Practice (Charities SORP (FRS 102)) and Financial Reporting Standard 102 (FRS 102). The financial statements are drawn up on the historical cost basis of accounting. The financial statements are prepared in sterling, which is the functional currency of the charity and rounded to the nearest £.

The trustees have prepared detailed forecasts and cashflow projections which they believe are based upon reasonable assumptions. The forecasts show that the charity should be able to operate for the foreseeable future and thus the trustees consider it appropriate to prepare the financial statements on a going concern basis.

b) Funds

General unrestricted funds represent the funds of the Society that are not subject to any restrictions regarding their use and are available for application on the general purposes of the Society.

Restricted funds are those subject to specific trusts, which may be declared by the donor or with their authority. The restricted funds of the Society are restricted income funds given for specific purposes, which are expendable at the discretion of the Executive Committee in accordance with particular activities of the Society.

c) Income

Voluntary income and donations (including legacies) are accounted for once the charity has entitlement to the income, it is probable the income will be received and the amount of income receivable can be reliably measured.

Subscriptions and mailing list sales represent amounts receivable during the year. Meetings income is recognised in the period when the meeting takes place and investment income (which represents interest on National Savings deposits and bank accounts) are the amounts receivable for the year.

d) Expenditure

Expenditure is accrued as soon as a liability is considered probable, discounted to present value for longer term liabilities.

Certain expenditure is directly attributable to specific activities and has been included in those cost categories. Support and governance costs attributable to more than one activity are apportioned across categories based on an estimate of the proportion of time spent by staff on those activities.

P a g e | 15

Grants and awards are accounted for when paid over, or when awarded, if that award creates a binding obligation on the charity.

P a g e | 16

THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021 (continued)

1. Accounting Policies (continued)

e) Joint arrangements

Where applicable the share of income and expenditure from joint arrangements to put on meetings in the year is accounted for under the appropriate heading in the Statement of Financial Activities.

f) Debtors

Grants receivable and other debtors are included at the settlement amount due. Prepayments are valued at the amount prepaid.

g) Cash at bank and in hand

Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of opening of the deposit.

h) Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation arising from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are recognised at their settlement amount.

i) Financial instruments

The charity only has financial assets and liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

j) Foreign currency translation

Transactions in foreign currency are translated at the rate ruling on the date of the transaction. Balances denominated in foreign currencies are retranslated at the yearend, with the gain or loss on retranslation going through the Statement of Financial Activities for the year.

2. Grants received

Grants of £35,000 (2020: £97,500) were received from The Company of Biologists during the year. £nil (2020: £62,500) of this was restricted as set out in Note 4 below, and £35,000 (2020: £35,000) was unrestricted.

3. Executive Committee members and employees

No Executive Committee member or any person connected with them, nor any of the Key Management Personnel received, or is due to receive, any remuneration for the year directly or indirectly from the Society's funds.

There were Nil Executive Committee members paid in 2021 (2020: nil) in respect of reimbursed travel, subsistence and accommodation expenses during the year. There were Nil third parties paid in 2021 (2020: nil) of costs for the Executive Committee to attend the Annual Spring Meeting. Nil (2020: nil) Executive Committee Members received Travel Grants of Nil (2020: £nil).

The Society has no employees.

Page 117

P a g e | 18

THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021 (continued)

4. Restricted funds

2021

2021	2021
Balance b/f £ Abercrombie Conference Fund 1,324 CoB/Honor Fell Travel Fund 41,096 CoB/PI Travel Fund 33,422 CoB/Training Course Fund 5,643 81,485		Incom e Expenditur e Transfer s Balance c/f £ £ £ £ - - - 1,324 - 3,109 - 37,987 - - - 33,422 - - - 5,643 - 3,109 - 78,376
	41,096	-	37,987
	33,422	-	33,422
	5,643	-	5,643
	81,485	-	78,376

2020

2020	2020
Balance b/f £ Abercrombie Conference Fund 1,824 CoB/Honor Fell Travel Fund 8,246 CoB/PI Travel Fund 13,422 CoB/Training Course Fund 643 24,135		Incom e Expenditur e Transfe rs Balance c/f £ £ £ £ - 500 - 1,324 37,500 4,650 - 41,096 20,000 - - 33,422 5,000 - - 5,643 62,500 5,150 - 81,485
	8,246	37,500	41,096
	13,422	20,000	33,422
	643	5,000	5,643
	24,135	62,500	81,485

The Abercrombie Conference Fund is money held on behalf of the Trustees of the Abercrombie Conference Fund which will be used to sponsor meetings on cell motility.

The CoB/Honor Fell Travel Fund relates to funds granted specifically to enable the making of grants to student delegates to cover the costs of travel to meetings of the Society.

The CoB/PI Travel Fund relates to grants made to members and principal Investigators to enable them to travel to cell biology meetings – not just BSCB meetings, but also other meetings where cell biology is covered.

The CoB/Training Course Fund relates to grants made to members to attend training courses.

Further details of the awards made in the year are given in the Executive Committee’s Report.

P a g e | 19

THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021 (continued)

5. Debtors						2020 £ 2,859 2020 £ 12,668	2020 £ 2,859 2020 £ 12,668
				2021
				£
Prepayments and accrued income				1,213
6. Creditors due within one year
				2021
				£
Accruals and deferred income			12,137
7 . Analysis of net assets by fund
	Unrestricte d		Restricte d				Total
	Funds		Funds				Funds
	£		£				£
Current assets	264,652		78,376				343,028
Current liabilities	(12,137)		-				(12,137 )
At 31 December 2021	252,515		78,376				330,891
	Unrestricte d		Restricte d				Total
	Funds		Funds				Funds
	£		£				£
Current assets	258,678		81,485				340,163
Current liabilities	(12,668)		-				(12,668 )
At 31 December 2020	246,010		81,485				327,495